About Equashield
Equashield is a company based in New York (United States) founded in 2009 by Eric Shem Tov and Marino Kriheli.. Equashield has raised $300 million across 1 funding round from investors including Nordic Capital. The company has 14 employees as of April 06, 2024. Equashield operates in a competitive market with competitors including ICU Medical, Carmel Pharma, Corvida Medical and Simplivia, among others.
- Headquarter New York, United States
- Employees 14 as on 06 Apr, 2024
- Founders Eric Shem Tov, Marino Kriheli
- Stage Unicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Equashield Llc
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$154.91 K (USD)2.44as on Mar 31, 2023
-
Net Profit
$-18.6 K (USD)-4093.6as on Mar 31, 2023
-
EBITDA
$-14.24 K (USD)-274.16as on Mar 31, 2023
-
Total Equity Funding
$300 M (USD)
in 1 rounds
-
Latest Funding Round
$300 M (USD), Series D
Oct 06, 2022
- Investors
-
Employee Count
14
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Equashield
Equashield has successfully raised a total of $300M through 1 strategic funding round. The most recent funding activity was a Series D round of $300 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series D — $300.0M
-
First Round
First Round
(06 Oct 2022)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Series D - Equashield | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Equashield
Equashield has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Nordic Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Equashield
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Equashield
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Equashield Comparisons
Competitors of Equashield
Equashield operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ICU Medical, Carmel Pharma, Corvida Medical and Simplivia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug and Infusion delivery devices
|
|
| domain | founded_year | HQ Location |
Closed-system transfer devices are produced for safe hazardous drug handling.
|
|
| domain | founded_year | HQ Location |
Closed system transfer device for safe administration of hazardous drugs
|
|
| domain | founded_year | HQ Location |
Manufactures closed system transfer devices to protect healthcare workers from drug exposure.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Equashield
Frequently Asked Questions about Equashield
When was Equashield founded?
Equashield was founded in 2009 and raised its 1st funding round 13 years after it was founded.
Where is Equashield located?
Equashield is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of Equashield?
Eric Shem Tov is the current CEO of Equashield. They have also founded this company.
Is Equashield a funded company?
Equashield is a funded company, having raised a total of $300M across 1 funding round to date. The company's 1st funding round was a Series D of $300M, raised on Oct 06, 2022.
How many employees does Equashield have?
As of Apr 06, 2024, the latest employee count at Equashield is 14.
What is the annual revenue of Equashield?
Annual revenue of Equashield is $154.91K as on Mar 31, 2023.
What does Equashield do?
Equashield was founded in 2009 and is based in New York, United States. Operations focus on the healthcare sector, where closed-system transfer devices are developed for managing hazardous drugs. The EQUASHIELD Pro automated compounding robot is utilized to prepare individual doses, ensuring accuracy while reducing errors in medication and dosage. Exposure risks to healthcare workers from hazardous drugs and vapors are mitigated through these systems.
Who are the top competitors of Equashield?
Equashield's top competitors include ICU Medical, Carmel Pharma and Corvida Medical.
Who are Equashield's investors?
Equashield has 1 investor. Key investors include Nordic Capital.
What is Equashield's valuation?
The valuation of Equashield is $1.3B as of Oct 2022.